L.M. Ching
Auckland Cancer Society Research Centre
Faculty of Medical and Health Sciences
The University of Auckland
Private Bag 92019
New Zealand
Name/email consistency: high
- Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice. Ching, L.M., Zwain, S., Baguley, B.C. Br. J. Cancer (2004)
- Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans. Lu, J., Helsby, N., Palmer, B.D., Tingle, M., Baguley, B.C., Kestell, P., Ching, L.M. J. Pharmacol. Exp. Ther. (2004)
- Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid. Ching, L.M., Cao, Z., Kieda, C., Zwain, S., Jameson, M.B., Baguley, B.C. Br. J. Cancer (2002)
- Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice. Ching, L.M., Goldsmith, D., Joseph, W.R., Körner, H., Sedgwick, J.D., Baguley, B.C. Cancer Res. (1999)
- Induction of STAT and NFkappaB activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell line. Ching, L.M., Young, H.A., Eberly, K., Yu, C.R. Biochem. Pharmacol. (1999)